Infección por COVID 19 como factor de riesgo de desarrollar preeclampsia temprana en el Hospital Regional Docente de Trujillo año 2020-2021
No Thumbnail Available
Date
2023-06-28
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Nacional de Trujillo
Abstract
La infección causada por COVID 19 se expandió rápidamente a lo largo del año 2020 y hasta la fecha siguen apareciendo diversas cepas, por tal razón los ginecólogos obstetras deben prepararse para atender cada vez más gestantes con COVID-19 y estar alertas ante un mayor riesgo de presentar preeclampsia temprana en estas pacientes, pudiendo modificar el curso de la enfermedad y/o mejorar resultados tanto en la madre, como en el hijo.
Por tal motivo se busca descubrir si existe mayor riesgo de preeclampsia temprana en gestantes con infección por SARS COV 2 en el Hospital Regional Docente de Trujillo. Se realizara un estudio analítico, observacional, retrospectivo, diseño de casos y controles. Se analizara la información obtenida de la base de datos de pacientes del departamento de ginecoobstetricia del Hospital Regional Docente de Trujillo, pacientes gestantes que desarrollaron preeclampsia temprana y de inicio tardío y de ellas, las que tengan infección por SARS COV 2 demostrada a través de una prueba molecular o antigénica y que tengan los registros completos de las variables en estudio; no se utiliza una ficha de recolección de datos.
Para la recolección de datos se utilizara el paquete estadístico SPSS V 26.0, verificar la asociación entre las variables en estudio se utilizará la prueba de chi cuadrado y para determinar el tipo de relación existente entre las variables, se obtendrá el Odss Ratio (OR) para COVID 19 en cuanto al riesgo de preeclampsia temprana, con su intervalo de confianza IC 95 %.
Abstract The infection caused by COVID 19 expanded rapidly throughout 2020 and to date various strains continue to appear, for this reason obstetrician-gynecologists must prepare to care for more and more pregnant women with COVID-19 and be alert to a higher risk of presenting early preeclampsia in these patients, which can modify the course of the disease and/or improve results in both the mother and the child. For this reason, we seek to discover if there is a higher risk of early preeclampsia in pregnant women with SARS COV 2 infection at the Trujillo Regional Teaching Hospital. An analytical, observational, retrospective, case-control design study will be carried out. The information obtained from the patient database of the gynecology-obstetrics department of the Trujillo Regional Teaching Hospital will be analyzed, pregnant patients who developed early and late-onset preeclampsia and of them, those who have SARS COV 2 infection demonstrated through a molecular or antigenic test and who have complete records of the variables under study; a data collection form is not used. For data collection, the SPSS V 26.0 statistical package will be used, to verify the association between the variables under study, the chi-square test will be used and to determine the type of relationship existing between the variables, the Odds Ratio (OR) for COVID 19 in terms of the risk of early preeclampsia will be obtained, with its 95% CI confidence interval.
Abstract The infection caused by COVID 19 expanded rapidly throughout 2020 and to date various strains continue to appear, for this reason obstetrician-gynecologists must prepare to care for more and more pregnant women with COVID-19 and be alert to a higher risk of presenting early preeclampsia in these patients, which can modify the course of the disease and/or improve results in both the mother and the child. For this reason, we seek to discover if there is a higher risk of early preeclampsia in pregnant women with SARS COV 2 infection at the Trujillo Regional Teaching Hospital. An analytical, observational, retrospective, case-control design study will be carried out. The information obtained from the patient database of the gynecology-obstetrics department of the Trujillo Regional Teaching Hospital will be analyzed, pregnant patients who developed early and late-onset preeclampsia and of them, those who have SARS COV 2 infection demonstrated through a molecular or antigenic test and who have complete records of the variables under study; a data collection form is not used. For data collection, the SPSS V 26.0 statistical package will be used, to verify the association between the variables under study, the chi-square test will be used and to determine the type of relationship existing between the variables, the Odds Ratio (OR) for COVID 19 in terms of the risk of early preeclampsia will be obtained, with its 95% CI confidence interval.
Description
Keywords
Covid, Embarazo, Preeclampsia Temprana, Factor de Riesgo